nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Thiotepa—urinary bladder cancer	0.192	0.426	CbGbCtD
Ropivacaine—CYP3A4—Thiotepa—urinary bladder cancer	0.059	0.131	CbGbCtD
Ropivacaine—CYP2B6—Cisplatin—urinary bladder cancer	0.053	0.118	CbGbCtD
Ropivacaine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0366	0.0812	CbGbCtD
Ropivacaine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0355	0.0788	CbGbCtD
Ropivacaine—CYP1A2—Etoposide—urinary bladder cancer	0.0306	0.0677	CbGbCtD
Ropivacaine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0172	0.0381	CbGbCtD
Ropivacaine—CYP3A4—Etoposide—urinary bladder cancer	0.016	0.0355	CbGbCtD
Ropivacaine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0109	0.0242	CbGbCtD
Ropivacaine—CYP1A2—urine—urinary bladder cancer	0.00365	0.103	CbGeAlD
Ropivacaine—SCN9A—prostate gland—urinary bladder cancer	0.0036	0.101	CbGeAlD
Ropivacaine—SCN4A—prostate gland—urinary bladder cancer	0.00321	0.0904	CbGeAlD
Ropivacaine—CYP3A4—urine—urinary bladder cancer	0.00264	0.0744	CbGeAlD
Ropivacaine—CYP2D6—urine—urinary bladder cancer	0.0026	0.0732	CbGeAlD
Ropivacaine—SCN3A—prostate gland—urinary bladder cancer	0.0025	0.0703	CbGeAlD
Ropivacaine—SCN4A—renal system—urinary bladder cancer	0.00219	0.0616	CbGeAlD
Ropivacaine—SCN3A—renal system—urinary bladder cancer	0.0017	0.0479	CbGeAlD
Ropivacaine—SCN2A—vagina—urinary bladder cancer	0.0014	0.0395	CbGeAlD
Ropivacaine—SCN3A—female reproductive system—urinary bladder cancer	0.00136	0.0384	CbGeAlD
Ropivacaine—SCN3A—vagina—urinary bladder cancer	0.00123	0.0347	CbGeAlD
Ropivacaine—SCN5A—vagina—urinary bladder cancer	0.00123	0.0346	CbGeAlD
Ropivacaine—SCN9A—lymph node—urinary bladder cancer	0.00115	0.0324	CbGeAlD
Ropivacaine—Lidocaine—EGFR—urinary bladder cancer	0.00111	1	CrCbGaD
Ropivacaine—CYP1A2—renal system—urinary bladder cancer	0.000893	0.0252	CbGeAlD
Ropivacaine—SCN10A—lymph node—urinary bladder cancer	0.000875	0.0246	CbGeAlD
Ropivacaine—CYP2B6—renal system—urinary bladder cancer	0.000856	0.0241	CbGeAlD
Ropivacaine—SCN3A—lymph node—urinary bladder cancer	0.000797	0.0225	CbGeAlD
Ropivacaine—CYP2B6—female reproductive system—urinary bladder cancer	0.000686	0.0193	CbGeAlD
Ropivacaine—CYP3A4—renal system—urinary bladder cancer	0.000647	0.0182	CbGeAlD
Ropivacaine—CYP2D6—renal system—urinary bladder cancer	0.000636	0.0179	CbGeAlD
Ropivacaine—CYP2B6—vagina—urinary bladder cancer	0.00062	0.0175	CbGeAlD
Ropivacaine—CYP3A4—female reproductive system—urinary bladder cancer	0.000518	0.0146	CbGeAlD
Ropivacaine—CYP2D6—female reproductive system—urinary bladder cancer	0.00051	0.0144	CbGeAlD
Ropivacaine—Hypotension—Etoposide—urinary bladder cancer	0.000266	0.000656	CcSEcCtD
Ropivacaine—Pain—Cisplatin—urinary bladder cancer	0.000265	0.000655	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000265	0.000653	CcSEcCtD
Ropivacaine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000263	0.000649	CcSEcCtD
Ropivacaine—Dysuria—Epirubicin—urinary bladder cancer	0.000262	0.000647	CcSEcCtD
Ropivacaine—Dizziness—Thiotepa—urinary bladder cancer	0.000262	0.000646	CcSEcCtD
Ropivacaine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000261	0.000644	CcSEcCtD
Ropivacaine—Urticaria—Fluorouracil—urinary bladder cancer	0.00026	0.000642	CcSEcCtD
Ropivacaine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000259	0.000639	CcSEcCtD
Ropivacaine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000256	0.000631	CcSEcCtD
Ropivacaine—Paraesthesia—Etoposide—urinary bladder cancer	0.000255	0.00063	CcSEcCtD
Ropivacaine—Haematuria—Methotrexate—urinary bladder cancer	0.000255	0.000628	CcSEcCtD
Ropivacaine—Dyspnoea—Etoposide—urinary bladder cancer	0.000253	0.000625	CcSEcCtD
Ropivacaine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000253	0.000624	CcSEcCtD
Ropivacaine—Somnolence—Etoposide—urinary bladder cancer	0.000253	0.000624	CcSEcCtD
Ropivacaine—Vomiting—Thiotepa—urinary bladder cancer	0.000252	0.000621	CcSEcCtD
Ropivacaine—Drowsiness—Epirubicin—urinary bladder cancer	0.00025	0.000617	CcSEcCtD
Ropivacaine—Rash—Thiotepa—urinary bladder cancer	0.000249	0.000616	CcSEcCtD
Ropivacaine—Dermatitis—Thiotepa—urinary bladder cancer	0.000249	0.000615	CcSEcCtD
Ropivacaine—Headache—Thiotepa—urinary bladder cancer	0.000248	0.000612	CcSEcCtD
Ropivacaine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000245	0.000605	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000245	0.000604	CcSEcCtD
Ropivacaine—Jaundice—Epirubicin—urinary bladder cancer	0.000244	0.000601	CcSEcCtD
Ropivacaine—Constipation—Etoposide—urinary bladder cancer	0.000243	0.0006	CcSEcCtD
Ropivacaine—Pain—Etoposide—urinary bladder cancer	0.000243	0.0006	CcSEcCtD
Ropivacaine—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000243	0.000599	CcSEcCtD
Ropivacaine—Dysuria—Doxorubicin—urinary bladder cancer	0.000242	0.000598	CcSEcCtD
Ropivacaine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000241	0.000595	CcSEcCtD
Ropivacaine—Asthenia—Gemcitabine—urinary bladder cancer	0.000239	0.000589	CcSEcCtD
Ropivacaine—Haematuria—Epirubicin—urinary bladder cancer	0.000238	0.000588	CcSEcCtD
Ropivacaine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000237	0.000584	CcSEcCtD
Ropivacaine—Pruritus—Gemcitabine—urinary bladder cancer	0.000236	0.000581	CcSEcCtD
Ropivacaine—Nausea—Thiotepa—urinary bladder cancer	0.000235	0.00058	CcSEcCtD
Ropivacaine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000235	0.00058	CcSEcCtD
Ropivacaine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000234	0.000578	CcSEcCtD
Ropivacaine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000234	0.000577	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000232	0.000574	CcSEcCtD
Ropivacaine—Pruritus—Fluorouracil—urinary bladder cancer	0.000232	0.000571	CcSEcCtD
Ropivacaine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000231	0.00057	CcSEcCtD
Ropivacaine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000229	0.000564	CcSEcCtD
Ropivacaine—Bradycardia—Epirubicin—urinary bladder cancer	0.000228	0.000563	CcSEcCtD
Ropivacaine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000228	0.000562	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000227	0.000559	CcSEcCtD
Ropivacaine—Urticaria—Etoposide—urinary bladder cancer	0.000226	0.000557	CcSEcCtD
Ropivacaine—Jaundice—Doxorubicin—urinary bladder cancer	0.000225	0.000556	CcSEcCtD
Ropivacaine—Rhinitis—Epirubicin—urinary bladder cancer	0.000225	0.000555	CcSEcCtD
Ropivacaine—Abdominal pain—Etoposide—urinary bladder cancer	0.000225	0.000555	CcSEcCtD
Ropivacaine—Body temperature increased—Etoposide—urinary bladder cancer	0.000225	0.000555	CcSEcCtD
Ropivacaine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000225	0.000555	CcSEcCtD
Ropivacaine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000224	0.000553	CcSEcCtD
Ropivacaine—Tinnitus—Methotrexate—urinary bladder cancer	0.000223	0.000551	CcSEcCtD
Ropivacaine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000223	0.000551	CcSEcCtD
Ropivacaine—Asthenia—Cisplatin—urinary bladder cancer	0.000223	0.000549	CcSEcCtD
Ropivacaine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000222	0.000549	CcSEcCtD
Ropivacaine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000221	0.000547	CcSEcCtD
Ropivacaine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000221	0.000545	CcSEcCtD
Ropivacaine—Haematuria—Doxorubicin—urinary bladder cancer	0.00022	0.000544	CcSEcCtD
Ropivacaine—Urethral disorder—Epirubicin—urinary bladder cancer	0.00022	0.000543	CcSEcCtD
Ropivacaine—Dizziness—Fluorouracil—urinary bladder cancer	0.000216	0.000534	CcSEcCtD
Ropivacaine—Chills—Methotrexate—urinary bladder cancer	0.000215	0.000531	CcSEcCtD
Ropivacaine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000212	0.000524	CcSEcCtD
Ropivacaine—Vomiting—Gemcitabine—urinary bladder cancer	0.000212	0.000522	CcSEcCtD
Ropivacaine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000211	0.000521	CcSEcCtD
Ropivacaine—Mental disorder—Methotrexate—urinary bladder cancer	0.00021	0.000518	CcSEcCtD
Ropivacaine—Rash—Gemcitabine—urinary bladder cancer	0.00021	0.000518	CcSEcCtD
Ropivacaine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00021	0.000518	CcSEcCtD
Ropivacaine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000209	0.000517	CcSEcCtD
Ropivacaine—Tinnitus—Epirubicin—urinary bladder cancer	0.000209	0.000516	CcSEcCtD
Ropivacaine—Erythema—Methotrexate—urinary bladder cancer	0.000209	0.000515	CcSEcCtD
Ropivacaine—Headache—Gemcitabine—urinary bladder cancer	0.000209	0.000515	CcSEcCtD
Ropivacaine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000208	0.000514	CcSEcCtD
Ropivacaine—Vomiting—Fluorouracil—urinary bladder cancer	0.000208	0.000514	CcSEcCtD
Ropivacaine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000208	0.000513	CcSEcCtD
Ropivacaine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000206	0.00051	CcSEcCtD
Ropivacaine—Rash—Fluorouracil—urinary bladder cancer	0.000206	0.000509	CcSEcCtD
Ropivacaine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000206	0.000509	CcSEcCtD
Ropivacaine—Headache—Fluorouracil—urinary bladder cancer	0.000205	0.000506	CcSEcCtD
Ropivacaine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000205	0.000506	CcSEcCtD
Ropivacaine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000204	0.000505	CcSEcCtD
Ropivacaine—Asthenia—Etoposide—urinary bladder cancer	0.000204	0.000503	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000203	0.000502	CcSEcCtD
Ropivacaine—Back pain—Methotrexate—urinary bladder cancer	0.000202	0.000498	CcSEcCtD
Ropivacaine—Chills—Epirubicin—urinary bladder cancer	0.000201	0.000497	CcSEcCtD
Ropivacaine—Pruritus—Etoposide—urinary bladder cancer	0.000201	0.000496	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—urinary bladder cancer	0.0002	0.000494	CcSEcCtD
Ropivacaine—Nausea—Gemcitabine—urinary bladder cancer	0.000198	0.000488	CcSEcCtD
Ropivacaine—Vomiting—Cisplatin—urinary bladder cancer	0.000197	0.000487	CcSEcCtD
Ropivacaine—Vision blurred—Methotrexate—urinary bladder cancer	0.000197	0.000485	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—urinary bladder cancer	0.000196	0.000485	CcSEcCtD
Ropivacaine—Rash—Cisplatin—urinary bladder cancer	0.000196	0.000483	CcSEcCtD
Ropivacaine—Dermatitis—Cisplatin—urinary bladder cancer	0.000195	0.000482	CcSEcCtD
Ropivacaine—Erythema—Epirubicin—urinary bladder cancer	0.000195	0.000482	CcSEcCtD
Ropivacaine—Diarrhoea—Etoposide—urinary bladder cancer	0.000194	0.00048	CcSEcCtD
Ropivacaine—Nausea—Fluorouracil—urinary bladder cancer	0.000194	0.00048	CcSEcCtD
Ropivacaine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000194	0.000478	CcSEcCtD
Ropivacaine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000193	0.000477	CcSEcCtD
Ropivacaine—Anaemia—Methotrexate—urinary bladder cancer	0.000193	0.000476	CcSEcCtD
Ropivacaine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000193	0.000475	CcSEcCtD
Ropivacaine—Tension—Epirubicin—urinary bladder cancer	0.000192	0.000473	CcSEcCtD
Ropivacaine—Nervousness—Epirubicin—urinary bladder cancer	0.00019	0.000468	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—urinary bladder cancer	0.000189	0.000466	CcSEcCtD
Ropivacaine—Malaise—Methotrexate—urinary bladder cancer	0.000188	0.000464	CcSEcCtD
Ropivacaine—Dizziness—Etoposide—urinary bladder cancer	0.000188	0.000464	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000188	0.000463	CcSEcCtD
Ropivacaine—Vertigo—Methotrexate—urinary bladder cancer	0.000187	0.000463	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—urinary bladder cancer	0.000186	0.00046	CcSEcCtD
Ropivacaine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000185	0.000458	CcSEcCtD
Ropivacaine—Nausea—Cisplatin—urinary bladder cancer	0.000184	0.000455	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—urinary bladder cancer	0.000184	0.000454	CcSEcCtD
Ropivacaine—Cough—Methotrexate—urinary bladder cancer	0.000182	0.000449	CcSEcCtD
Ropivacaine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000182	0.000449	CcSEcCtD
Ropivacaine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000181	0.000447	CcSEcCtD
Ropivacaine—Convulsion—Methotrexate—urinary bladder cancer	0.000181	0.000446	CcSEcCtD
Ropivacaine—Vomiting—Etoposide—urinary bladder cancer	0.000181	0.000446	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—urinary bladder cancer	0.000181	0.000446	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—urinary bladder cancer	0.00018	0.000445	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—urinary bladder cancer	0.000179	0.000443	CcSEcCtD
Ropivacaine—Rash—Etoposide—urinary bladder cancer	0.000179	0.000442	CcSEcCtD
Ropivacaine—Dermatitis—Etoposide—urinary bladder cancer	0.000179	0.000442	CcSEcCtD
Ropivacaine—Headache—Etoposide—urinary bladder cancer	0.000178	0.000439	CcSEcCtD
Ropivacaine—Myalgia—Methotrexate—urinary bladder cancer	0.000178	0.000438	CcSEcCtD
Ropivacaine—Chest pain—Methotrexate—urinary bladder cancer	0.000178	0.000438	CcSEcCtD
Ropivacaine—Arthralgia—Methotrexate—urinary bladder cancer	0.000178	0.000438	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—urinary bladder cancer	0.000177	0.000437	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—urinary bladder cancer	0.000176	0.000435	CcSEcCtD
Ropivacaine—Discomfort—Methotrexate—urinary bladder cancer	0.000175	0.000433	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—urinary bladder cancer	0.000175	0.000433	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—urinary bladder cancer	0.000175	0.000433	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—urinary bladder cancer	0.000175	0.000432	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—urinary bladder cancer	0.000175	0.000431	CcSEcCtD
Ropivacaine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000174	0.000429	CcSEcCtD
Ropivacaine—Confusional state—Methotrexate—urinary bladder cancer	0.000172	0.000424	CcSEcCtD
Ropivacaine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000172	0.000423	CcSEcCtD
Ropivacaine—Cough—Epirubicin—urinary bladder cancer	0.00017	0.00042	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00017	0.00042	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00017	0.00042	CcSEcCtD
Ropivacaine—Convulsion—Epirubicin—urinary bladder cancer	0.000169	0.000417	CcSEcCtD
Ropivacaine—Infection—Methotrexate—urinary bladder cancer	0.000169	0.000417	CcSEcCtD
Ropivacaine—Nausea—Etoposide—urinary bladder cancer	0.000169	0.000417	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—urinary bladder cancer	0.000169	0.000416	CcSEcCtD
Ropivacaine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000168	0.000414	CcSEcCtD
Ropivacaine—Anaemia—Doxorubicin—urinary bladder cancer	0.000167	0.000412	CcSEcCtD
Ropivacaine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000167	0.000411	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—urinary bladder cancer	0.000166	0.00041	CcSEcCtD
Ropivacaine—Chest pain—Epirubicin—urinary bladder cancer	0.000166	0.00041	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—urinary bladder cancer	0.000166	0.00041	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—urinary bladder cancer	0.000166	0.00041	CcSEcCtD
Ropivacaine—Anxiety—Epirubicin—urinary bladder cancer	0.000166	0.000409	CcSEcCtD
Ropivacaine—Skin disorder—Methotrexate—urinary bladder cancer	0.000165	0.000408	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000165	0.000406	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—urinary bladder cancer	0.000164	0.000405	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—urinary bladder cancer	0.000163	0.000402	CcSEcCtD
Ropivacaine—Vertigo—Doxorubicin—urinary bladder cancer	0.000162	0.000401	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—urinary bladder cancer	0.000162	0.0004	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—urinary bladder cancer	0.000161	0.000397	CcSEcCtD
Ropivacaine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000159	0.000393	CcSEcCtD
Ropivacaine—Hypotension—Methotrexate—urinary bladder cancer	0.000159	0.000393	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000159	0.000392	CcSEcCtD
Ropivacaine—Infection—Epirubicin—urinary bladder cancer	0.000158	0.000391	CcSEcCtD
Ropivacaine—Cough—Doxorubicin—urinary bladder cancer	0.000158	0.000389	CcSEcCtD
Ropivacaine—Shock—Epirubicin—urinary bladder cancer	0.000157	0.000387	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—urinary bladder cancer	0.000157	0.000386	CcSEcCtD
Ropivacaine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000156	0.000385	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—urinary bladder cancer	0.000156	0.000385	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—urinary bladder cancer	0.000156	0.000384	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000155	0.000383	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—urinary bladder cancer	0.000155	0.000382	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000154	0.00038	CcSEcCtD
Ropivacaine—Insomnia—Methotrexate—urinary bladder cancer	0.000154	0.00038	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000154	0.00038	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—urinary bladder cancer	0.000154	0.00038	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—urinary bladder cancer	0.000154	0.00038	CcSEcCtD
Ropivacaine—Anxiety—Doxorubicin—urinary bladder cancer	0.000153	0.000378	CcSEcCtD
Ropivacaine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000153	0.000377	CcSEcCtD
Ropivacaine—Discomfort—Doxorubicin—urinary bladder cancer	0.000152	0.000375	CcSEcCtD
Ropivacaine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000152	0.000375	CcSEcCtD
Ropivacaine—Somnolence—Methotrexate—urinary bladder cancer	0.000151	0.000374	CcSEcCtD
Ropivacaine—Dyspepsia—Methotrexate—urinary bladder cancer	0.00015	0.00037	CcSEcCtD
Ropivacaine—Hypotension—Epirubicin—urinary bladder cancer	0.000149	0.000367	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—urinary bladder cancer	0.000149	0.000367	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000147	0.000364	CcSEcCtD
Ropivacaine—Infection—Doxorubicin—urinary bladder cancer	0.000146	0.000361	CcSEcCtD
Ropivacaine—Pain—Methotrexate—urinary bladder cancer	0.000146	0.000359	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000145	0.000358	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—urinary bladder cancer	0.000145	0.000358	CcSEcCtD
Ropivacaine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000144	0.000356	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—urinary bladder cancer	0.000144	0.000356	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000144	0.000355	CcSEcCtD
Ropivacaine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000143	0.000353	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000143	0.000353	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000143	0.000352	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000142	0.000351	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—urinary bladder cancer	0.000142	0.00035	CcSEcCtD
Ropivacaine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00014	0.000346	CcSEcCtD
Ropivacaine—Dyspepsia—Epirubicin—urinary bladder cancer	0.00014	0.000346	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000139	0.000344	CcSEcCtD
Ropivacaine—Hypotension—Doxorubicin—urinary bladder cancer	0.000138	0.00034	CcSEcCtD
Ropivacaine—Constipation—Epirubicin—urinary bladder cancer	0.000136	0.000336	CcSEcCtD
Ropivacaine—Pain—Epirubicin—urinary bladder cancer	0.000136	0.000336	CcSEcCtD
Ropivacaine—Urticaria—Methotrexate—urinary bladder cancer	0.000135	0.000334	CcSEcCtD
Ropivacaine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000135	0.000332	CcSEcCtD
Ropivacaine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000135	0.000332	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000134	0.000331	CcSEcCtD
Ropivacaine—Insomnia—Doxorubicin—urinary bladder cancer	0.000133	0.000329	CcSEcCtD
Ropivacaine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000132	0.000327	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000131	0.000324	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000131	0.000324	CcSEcCtD
Ropivacaine—Somnolence—Doxorubicin—urinary bladder cancer	0.000131	0.000323	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00013	0.000322	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00013	0.00032	CcSEcCtD
Ropivacaine—Urticaria—Epirubicin—urinary bladder cancer	0.000127	0.000312	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—urinary bladder cancer	0.000126	0.000311	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—urinary bladder cancer	0.000126	0.000311	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000126	0.000311	CcSEcCtD
Ropivacaine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000126	0.000311	CcSEcCtD
Ropivacaine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000125	0.00031	CcSEcCtD
Ropivacaine—Asthenia—Methotrexate—urinary bladder cancer	0.000122	0.000301	CcSEcCtD
Ropivacaine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000121	0.0003	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000121	0.000298	CcSEcCtD
Ropivacaine—Pruritus—Methotrexate—urinary bladder cancer	0.00012	0.000297	CcSEcCtD
Ropivacaine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000117	0.00029	CcSEcCtD
Ropivacaine—Urticaria—Doxorubicin—urinary bladder cancer	0.000117	0.000289	CcSEcCtD
Ropivacaine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000117	0.000288	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000117	0.000288	CcSEcCtD
Ropivacaine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000116	0.000288	CcSEcCtD
Ropivacaine—Asthenia—Epirubicin—urinary bladder cancer	0.000114	0.000282	CcSEcCtD
Ropivacaine—Pruritus—Epirubicin—urinary bladder cancer	0.000113	0.000278	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—MMP9—urinary bladder cancer	0.000113	0.00105	CbGpPWpGaD
Ropivacaine—Dizziness—Methotrexate—urinary bladder cancer	0.000113	0.000278	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—SRC—urinary bladder cancer	0.000113	0.00105	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CREBBP—urinary bladder cancer	0.000112	0.00105	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CREBBP—urinary bladder cancer	0.000112	0.00105	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000111	0.00103	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00011	0.00103	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00011	0.00103	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—RHOA—urinary bladder cancer	0.00011	0.00102	CbGpPWpGaD
Ropivacaine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000109	0.000269	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000109	0.000268	CcSEcCtD
Ropivacaine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000108	0.00101	CbGpPWpGaD
Ropivacaine—Vomiting—Methotrexate—urinary bladder cancer	0.000108	0.000267	CcSEcCtD
Ropivacaine—SCN4A—Axon guidance—SRC—urinary bladder cancer	0.000108	0.00101	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—SRC—urinary bladder cancer	0.000108	0.00101	CbGpPWpGaD
Ropivacaine—Rash—Methotrexate—urinary bladder cancer	0.000107	0.000265	CcSEcCtD
Ropivacaine—Dermatitis—Methotrexate—urinary bladder cancer	0.000107	0.000265	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—EP300—urinary bladder cancer	0.000107	0.000997	CbGpPWpGaD
Ropivacaine—Headache—Methotrexate—urinary bladder cancer	0.000107	0.000263	CcSEcCtD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000107	0.000996	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—ERBB2—urinary bladder cancer	0.000106	0.000992	CbGpPWpGaD
Ropivacaine—Asthenia—Doxorubicin—urinary bladder cancer	0.000106	0.000261	CcSEcCtD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000106	0.000987	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—RHOA—urinary bladder cancer	0.000105	0.000984	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—RHOA—urinary bladder cancer	0.000105	0.000984	CbGpPWpGaD
Ropivacaine—Dizziness—Epirubicin—urinary bladder cancer	0.000105	0.00026	CcSEcCtD
Ropivacaine—Pruritus—Doxorubicin—urinary bladder cancer	0.000104	0.000257	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—SRC—urinary bladder cancer	0.000104	0.000974	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—SRC—urinary bladder cancer	0.000104	0.000974	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—SRC—urinary bladder cancer	0.000104	0.00097	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—urinary bladder cancer	0.000103	0.000963	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—HRAS—urinary bladder cancer	0.000102	0.000956	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—RHOA—urinary bladder cancer	0.000102	0.000949	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—RHOA—urinary bladder cancer	0.000102	0.000949	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ERBB2—urinary bladder cancer	0.000102	0.000948	CbGpPWpGaD
Ropivacaine—Vomiting—Epirubicin—urinary bladder cancer	0.000101	0.00025	CcSEcCtD
Ropivacaine—Nausea—Methotrexate—urinary bladder cancer	0.000101	0.00025	CcSEcCtD
Ropivacaine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000101	0.000249	CcSEcCtD
Ropivacaine—Rash—Epirubicin—urinary bladder cancer	0.0001	0.000248	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—urinary bladder cancer	0.0001	0.000248	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—RHOA—urinary bladder cancer	0.0001	0.000935	CbGpPWpGaD
Ropivacaine—Headache—Epirubicin—urinary bladder cancer	9.98e-05	0.000246	CcSEcCtD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	9.96e-05	0.00093	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—urinary bladder cancer	9.87e-05	0.000921	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ERBB2—urinary bladder cancer	9.76e-05	0.000911	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ERBB2—urinary bladder cancer	9.76e-05	0.000911	CbGpPWpGaD
Ropivacaine—Dizziness—Doxorubicin—urinary bladder cancer	9.75e-05	0.000241	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—KRAS—urinary bladder cancer	9.74e-05	0.00091	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	9.48e-05	0.000885	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	9.48e-05	0.000885	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—urinary bladder cancer	9.48e-05	0.000885	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—urinary bladder cancer	9.48e-05	0.000885	CbGpPWpGaD
Ropivacaine—Nausea—Epirubicin—urinary bladder cancer	9.46e-05	0.000234	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—ERBB2—urinary bladder cancer	9.41e-05	0.000879	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	9.41e-05	0.000879	CbGpPWpGaD
Ropivacaine—Vomiting—Doxorubicin—urinary bladder cancer	9.37e-05	0.000231	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—KRAS—urinary bladder cancer	9.32e-05	0.00087	CbGpPWpGaD
Ropivacaine—Rash—Doxorubicin—urinary bladder cancer	9.3e-05	0.000229	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—urinary bladder cancer	9.29e-05	0.000229	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	9.27e-05	0.000866	CbGpPWpGaD
Ropivacaine—Headache—Doxorubicin—urinary bladder cancer	9.24e-05	0.000228	CcSEcCtD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	9.22e-05	0.000861	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	9.22e-05	0.000861	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—urinary bladder cancer	9.14e-05	0.000853	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—urinary bladder cancer	9.14e-05	0.000853	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP9—urinary bladder cancer	9.11e-05	0.000851	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—urinary bladder cancer	9.1e-05	0.00085	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	9.05e-05	0.000845	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	9.04e-05	0.000844	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—KRAS—urinary bladder cancer	8.95e-05	0.000836	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—KRAS—urinary bladder cancer	8.95e-05	0.000836	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.92e-05	0.000833	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	8.79e-05	0.000821	CbGpPWpGaD
Ropivacaine—Nausea—Doxorubicin—urinary bladder cancer	8.76e-05	0.000216	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—MMP9—urinary bladder cancer	8.71e-05	0.000813	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—urinary bladder cancer	8.67e-05	0.000809	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EP300—urinary bladder cancer	8.64e-05	0.000806	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—KRAS—urinary bladder cancer	8.63e-05	0.000806	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—KRAS—urinary bladder cancer	8.63e-05	0.000806	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—KRAS—urinary bladder cancer	8.6e-05	0.000803	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.53e-05	0.000796	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—SRC—urinary bladder cancer	8.4e-05	0.000784	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP9—urinary bladder cancer	8.37e-05	0.000782	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP9—urinary bladder cancer	8.37e-05	0.000782	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	8.31e-05	0.000776	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—HRAS—urinary bladder cancer	8.28e-05	0.000773	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.26e-05	0.000771	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EP300—urinary bladder cancer	8.26e-05	0.000771	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.23e-05	0.000768	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	8.22e-05	0.000768	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.2e-05	0.000765	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.08e-05	0.000755	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.08e-05	0.000755	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	8.07e-05	0.000754	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—urinary bladder cancer	8.07e-05	0.000754	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—SRC—urinary bladder cancer	8.03e-05	0.00075	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	7.97e-05	0.000744	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—urinary bladder cancer	7.95e-05	0.000742	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EP300—urinary bladder cancer	7.94e-05	0.000741	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EP300—urinary bladder cancer	7.94e-05	0.000741	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—urinary bladder cancer	7.92e-05	0.00074	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	7.9e-05	0.000738	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—SRC—urinary bladder cancer	7.72e-05	0.000721	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—SRC—urinary bladder cancer	7.72e-05	0.000721	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	7.7e-05	0.000719	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	7.7e-05	0.000719	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	7.66e-05	0.000715	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EP300—urinary bladder cancer	7.65e-05	0.000715	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EP300—urinary bladder cancer	7.65e-05	0.000715	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	7.63e-05	0.000713	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—HRAS—urinary bladder cancer	7.61e-05	0.000711	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—urinary bladder cancer	7.61e-05	0.000711	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	7.56e-05	0.000706	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NAT1—urinary bladder cancer	7.56e-05	0.000706	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.56e-05	0.000706	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—SRC—urinary bladder cancer	7.44e-05	0.000695	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—SRC—urinary bladder cancer	7.44e-05	0.000695	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	7.36e-05	0.000687	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—urinary bladder cancer	7.34e-05	0.000685	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—urinary bladder cancer	7.34e-05	0.000685	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—SRC—urinary bladder cancer	7.33e-05	0.000685	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—urinary bladder cancer	7.31e-05	0.000682	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	7.15e-05	0.000667	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—urinary bladder cancer	7.04e-05	0.000657	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.04e-05	0.000657	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—urinary bladder cancer	7.01e-05	0.000655	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	6.95e-05	0.000649	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.94e-05	0.000648	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	6.91e-05	0.000645	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—urinary bladder cancer	6.76e-05	0.000632	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	6.76e-05	0.000632	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—urinary bladder cancer	6.7e-05	0.000626	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—urinary bladder cancer	6.65e-05	0.000621	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	6.61e-05	0.000618	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	6.52e-05	0.000609	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	6.52e-05	0.000609	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.49e-05	0.000606	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—urinary bladder cancer	6.44e-05	0.000601	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—urinary bladder cancer	6.44e-05	0.000601	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—urinary bladder cancer	6.43e-05	0.0006	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—urinary bladder cancer	6.39e-05	0.000597	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	6.39e-05	0.000597	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	6.22e-05	0.000581	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—urinary bladder cancer	6.21e-05	0.00058	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—urinary bladder cancer	6.21e-05	0.00058	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	6.16e-05	0.000575	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	6.16e-05	0.000575	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—urinary bladder cancer	6.07e-05	0.000567	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.91e-05	0.000552	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	5.91e-05	0.000552	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	5.88e-05	0.000549	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.83e-05	0.000544	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	5.73e-05	0.000535	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	5.67e-05	0.00053	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—urinary bladder cancer	5.65e-05	0.000528	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	5.54e-05	0.000517	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.43e-05	0.000507	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—urinary bladder cancer	5.43e-05	0.000507	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	5.43e-05	0.000507	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EP300—urinary bladder cancer	5.38e-05	0.000502	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.36e-05	0.0005	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	5.25e-05	0.00049	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	5.25e-05	0.00049	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	5.24e-05	0.000489	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	5.24e-05	0.000489	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—SRC—urinary bladder cancer	5.23e-05	0.000488	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—urinary bladder cancer	5.16e-05	0.000482	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	4.8e-05	0.000448	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.69e-05	0.000438	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	4.59e-05	0.000428	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.58e-05	0.000427	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.45e-05	0.000415	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.45e-05	0.000415	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.38e-05	0.000409	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—urinary bladder cancer	4.37e-05	0.000408	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	4.33e-05	0.000404	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.32e-05	0.000404	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	4.14e-05	0.000387	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.08e-05	0.000381	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.07e-05	0.00038	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.98e-05	0.000372	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	3.68e-05	0.000344	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.66e-05	0.000342	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.62e-05	0.000338	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.57e-05	0.000334	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.46e-05	0.000323	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.43e-05	0.000321	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.43e-05	0.000321	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.37e-05	0.000315	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.31e-05	0.000309	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.31e-05	0.000309	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.21e-05	0.0003	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.18e-05	0.000297	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.14e-05	0.000293	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.88e-05	0.000269	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.83e-05	0.000264	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.7e-05	0.000252	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.7e-05	0.000252	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.67e-05	0.000249	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.67e-05	0.000249	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.6e-05	0.000243	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.59e-05	0.000242	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.48e-05	0.000232	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.44e-05	0.000228	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.3e-05	0.000215	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.3e-05	0.000215	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.23e-05	0.000208	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.22e-05	0.000208	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.1e-05	0.000196	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.08e-05	0.000194	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.07e-05	0.000193	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.04e-05	0.000191	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.04e-05	0.000191	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.96e-05	0.000183	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.95e-05	0.000182	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.95e-05	0.000182	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.94e-05	0.000181	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.92e-05	0.00018	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.89e-05	0.000176	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.88e-05	0.000176	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.86e-05	0.000174	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.85e-05	0.000173	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.81e-05	0.000169	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.62e-05	0.000152	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.57e-05	0.000147	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.55e-05	0.000144	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.52e-05	0.000142	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.5e-05	0.00014	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.5e-05	0.00014	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.47e-05	0.000137	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.46e-05	0.000136	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.44e-05	0.000134	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.42e-05	0.000133	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.42e-05	0.000133	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.41e-05	0.000131	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.36e-05	0.000127	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.34e-05	0.000125	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.33e-05	0.000124	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.31e-05	0.000122	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.27e-05	0.000118	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.26e-05	0.000117	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.22e-05	0.000114	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.21e-05	0.000113	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	0.000112	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	0.000112	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.15e-05	0.000108	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.15e-05	0.000108	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	0.000106	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	9.94e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.02e-05	9.51e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.01e-05	9.44e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.01e-05	9.39e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	9.78e-06	9.14e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—EP300—urinary bladder cancer	9.59e-06	8.95e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.4e-06	8.78e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.29e-06	8.68e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.29e-06	8.68e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.9e-06	8.31e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.74e-06	8.16e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.63e-06	8.06e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.29e-06	7.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.21e-06	7.67e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	8.01e-06	7.48e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.99e-06	6.52e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.79e-06	6.34e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.66e-06	6.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.66e-06	6.22e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.4e-06	5.97e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.92e-06	5.53e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.64e-06	5.27e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.24e-06	4.89e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.57e-06	4.27e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.36e-06	4.07e-05	CbGpPWpGaD
